Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2018

Open Access 01-12-2018 | Short report

Non-typeable Haemophilus Influenzae detection in the lower airways of patients with lung cancer and chronic obstructive pulmonary disease

Authors: Krishna B. Sriram, Amanda J. Cox, Pathmanathan Sivakumaran, Maninder Singh, Annabelle M. Watts, Nicholas P. West, Allan W. Cripps

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2018

Login to get access

Abstract

Background

Chronic airway inflammation and hypersensitivity to bacterial infection may contribute to lung cancer pathogenesis. Previous studies have demonstrated that nontypeable Haemophilus influenzae (NTHi) is the most common colonizing bacteria in the lower airways of patients with COPD. The objective of this study was to determine the presence of NTHi and immunoglobulin concentrations in patients with lung cancer, COPD and controls.

Methods

Serum and bronchial wash samples were collected from patients undergoing diagnostic bronchoscopy. Total IgE, IgG and specific NTHi IgG were measured by enzyme linked immunosorbent assay. Bronchial wash samples were examined for the presence of NTHi via PCR.

Results

Out of the 60 patients: 20 had confirmed Lung Cancer, 27 had COPD only and 13 were used as Controls. NTHi was detected in the lower airways of all three groups (Lung Cancer 20%; COPD 22% and Controls 15%). Total IgE was highest in Lung Cancer subjects followed by COPD and control subjects (mean ± SD: 870 ± 944, 381 ± 442, 159 ± 115). Likewise total IgG was higher in Lung cancer (Mean ± SD: 6.99 ± 1.8) patients compared to COPD (Mean ± SD: 5.43 ± 2).

Conclusions

The lack of difference in NTHi and specific antibodies between the three groups makes it less likely that NTHi has an important pathogenetic role in subjects with Lung Cancer. However the detection of higher IgE antibody in Lung Cancer subjects identifies a possible mechanism for carcinogenesis in these subjects and warrants further study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of Cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev. 2010;19:1893–907.CrossRef Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of Cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev. 2010;19:1893–907.CrossRef
2.
go back to reference Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379:1341–51.CrossRefPubMed Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379:1341–51.CrossRefPubMed
3.
go back to reference Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung Cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst. 2009;101:554–9.CrossRefPubMedPubMedCentral Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung Cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst. 2009;101:554–9.CrossRefPubMedPubMedCentral
4.
go back to reference Shapiro SD. End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on. Am J Respir Crit Care Med. 2001;164:339–40.CrossRefPubMed Shapiro SD. End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on. Am J Respir Crit Care Med. 2001;164:339–40.CrossRefPubMed
5.
go back to reference Barta P, Van Pelt C, Men T, Dickey B, Lotan R, Moghaddam SJ. Enhancement of lung tumorigenesis in a Gprc5a knockout mouse by chronic extrinsic airway inflammation. Mol Cancer. 2012;11:4.CrossRefPubMedPubMedCentral Barta P, Van Pelt C, Men T, Dickey B, Lotan R, Moghaddam SJ. Enhancement of lung tumorigenesis in a Gprc5a knockout mouse by chronic extrinsic airway inflammation. Mol Cancer. 2012;11:4.CrossRefPubMedPubMedCentral
6.
go back to reference Moghaddam SJ, Li H, Cho S-N, Dishop MK, Wistuba II, Ji L, et al. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease–like airway inflammation in a K-ras–induced mouse model. Am J Respir Cell Mol Biol. 2009;40:443–53. Moghaddam SJ, Li H, Cho S-N, Dishop MK, Wistuba II, Ji L, et al. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease–like airway inflammation in a K-ras–induced mouse model. Am J Respir Cell Mol Biol. 2009;40:443–53.
7.
go back to reference Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001;14:336–63.CrossRefPubMedPubMedCentral Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001;14:336–63.CrossRefPubMedPubMedCentral
8.
go back to reference Laroumagne S, Lepage B, Hermant C, Plat G, Phelippeau M, Bigay-Game L, et al. Bronchial colonisation in patients with lung cancer: a prospective study. Eur Respir J. 2013;42:220–9. Laroumagne S, Lepage B, Hermant C, Plat G, Phelippeau M, Bigay-Game L, et al. Bronchial colonisation in patients with lung cancer: a prospective study. Eur Respir J. 2013;42:220–9.
9.
go back to reference DC O, RL C, AW C. Haemophilus influenzae and smoking-related obstructive airways disease. Int J COPD. 2011;6:345–51. DC O, RL C, AW C. Haemophilus influenzae and smoking-related obstructive airways disease. Int J COPD. 2011;6:345–51.
10.
go back to reference Willner D, Daly J, Whiley D, Grimwood K, Wainwright CE, Hugenholtz P. Comparison of DNA extraction methods for microbial community profiling with an application to pediatric Bronchoalveolar lavage samples. PLoS One. 2012;7:e34605.CrossRefPubMedPubMedCentral Willner D, Daly J, Whiley D, Grimwood K, Wainwright CE, Hugenholtz P. Comparison of DNA extraction methods for microbial community profiling with an application to pediatric Bronchoalveolar lavage samples. PLoS One. 2012;7:e34605.CrossRefPubMedPubMedCentral
11.
go back to reference Price EP, Sarovich DS, Nosworthy E, Beissbarth J, Marsh RL, Pickering J, et al. Haemophilus influenzae: using comparative genomics to accurately identify a highly recombinogenic human pathogen. BMC Genomics. 2015;16:1–10. Price EP, Sarovich DS, Nosworthy E, Beissbarth J, Marsh RL, Pickering J, et al. Haemophilus influenzae: using comparative genomics to accurately identify a highly recombinogenic human pathogen. BMC Genomics. 2015;16:1–10.
12.
go back to reference Wroblewski D, Halse TA, Hayes J, Kohlerschmidt D, Musser KA. Utilization of a real-time PCR approach for Haemophilus influenzae serotype determination as an alternative to the slide agglutination test. Mol Cell Probes. 2013;27:86–9.CrossRefPubMed Wroblewski D, Halse TA, Hayes J, Kohlerschmidt D, Musser KA. Utilization of a real-time PCR approach for Haemophilus influenzae serotype determination as an alternative to the slide agglutination test. Mol Cell Probes. 2013;27:86–9.CrossRefPubMed
13.
go back to reference Kyd JM, Taylor D, Cripps AW. Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae. Infect Immun. 1994;62:5652–8.PubMedPubMedCentral Kyd JM, Taylor D, Cripps AW. Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae. Infect Immun. 1994;62:5652–8.PubMedPubMedCentral
14.
15.
go back to reference Ioanas M, Angrill J, Baldo X, Arancibia F, Gonzalez J, Bauer T, et al. Bronchial bacterial colonization in patients with resectable lung carcinoma. Eur Respir J. 2002;19:326–32. Ioanas M, Angrill J, Baldo X, Arancibia F, Gonzalez J, Bauer T, et al. Bronchial bacterial colonization in patients with resectable lung carcinoma. Eur Respir J. 2002;19:326–32.
16.
go back to reference Balestro E, Baraldo S, Piloni D, Stella G. Lung tumors, COPD and immune response: is epigenetic the bottom line? Minerva Med. 2016;107:1–8.PubMed Balestro E, Baraldo S, Piloni D, Stella G. Lung tumors, COPD and immune response: is epigenetic the bottom line? Minerva Med. 2016;107:1–8.PubMed
17.
go back to reference Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer. 2006;118:3124–32.CrossRefPubMed Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer. 2006;118:3124–32.CrossRefPubMed
18.
go back to reference Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005;60:1098–111.CrossRefPubMed Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005;60:1098–111.CrossRefPubMed
19.
go back to reference Wang H, Rothenbacher D, Löw M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119:695–701.CrossRefPubMed Wang H, Rothenbacher D, Löw M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119:695–701.CrossRefPubMed
21.
go back to reference Merrill RM, Isakson RT, Beck RE. The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol. 2007;99:102–17.CrossRefPubMed Merrill RM, Isakson RT, Beck RE. The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol. 2007;99:102–17.CrossRefPubMed
22.
go back to reference Hällgren R, Nόu E, Arrendal H, Hiesche K. Smoking and circulating IgE in bronchial carcinoma. Acta Med Scand. 1982;211:269–73.CrossRefPubMed Hällgren R, Nόu E, Arrendal H, Hiesche K. Smoking and circulating IgE in bronchial carcinoma. Acta Med Scand. 1982;211:269–73.CrossRefPubMed
23.
go back to reference Taghizadeh N, Vonk JM, Hospers JJ, Postma DS, de Vries EGE, Schouten JP, et al. Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort. Cancer Causes Control. 2015;26:99–109. Taghizadeh N, Vonk JM, Hospers JJ, Postma DS, de Vries EGE, Schouten JP, et al. Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort. Cancer Causes Control. 2015;26:99–109.
24.
go back to reference Mensinga TT, Schouten JP, Rijcken B, Weiss ST, Speizer FE, Lende R. The relationship of eosinophilia and positive skin test reactivity to respiratory symptom prevalence in a community-based population study. J Allergy Clin Immunol. 1990;86:99–107. Mensinga TT, Schouten JP, Rijcken B, Weiss ST, Speizer FE, Lende R. The relationship of eosinophilia and positive skin test reactivity to respiratory symptom prevalence in a community-based population study. J Allergy Clin Immunol. 1990;86:99–107.
25.
go back to reference Hosgood HD, Sapkota AR, Rothman N, Rohan T, Hu W, Xu J, et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ Mol Mutagen. 2014;55:643–51. Hosgood HD, Sapkota AR, Rothman N, Rohan T, Hu W, Xu J, et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ Mol Mutagen. 2014;55:643–51.
Metadata
Title
Non-typeable Haemophilus Influenzae detection in the lower airways of patients with lung cancer and chronic obstructive pulmonary disease
Authors
Krishna B. Sriram
Amanda J. Cox
Pathmanathan Sivakumaran
Maninder Singh
Annabelle M. Watts
Nicholas P. West
Allan W. Cripps
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2018
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-018-0123-x

Other articles of this Issue 1/2018

Multidisciplinary Respiratory Medicine 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.